Reactions Weekly

, Volume 1636, Issue 1, pp 169–169 | Cite as

Imatinib

Various toxicities: 11 case reports
Case report
  • 29 Downloads

Reference

  1. Magro L, et al. Imatinib mesylate as salvage therapy for refractory sclerotic chronic graft-versus-host disease. Blood 114: 719-22, No. 3, 16 Jul 2009. Available from: URL: http://doi.org/10.1182/blood-2009-02-204750 - FranceCrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Personalised recommendations